gp100 (154-162)

gp100 (154-162) is a synthetic peptide fragment derived from the human glycoprotein 100, an integral membrane protein commonly associated with melanocyte biology and melanoma research. Representing amino acids 154 to 162 of the gp100 sequence, this peptide is frequently utilized as a model antigenic epitope in immunological studies due to its well-characterized role in T cell recognition. Its defined sequence and established relevance in antigen processing and presentation make it a valuable tool for dissecting immune responses, particularly in the context of tumor immunology and antigen-specific cellular assays. Researchers leverage this peptide to explore the molecular underpinnings of antigen recognition, epitope mapping, and cellular activation within controlled experimental systems.

Antigen Presentation Studies: The gp100 (154-162) peptide serves as a precise model for investigating the mechanisms of antigen processing and presentation via major histocompatibility complex (MHC) class I molecules. By loading this epitope onto antigen-presenting cells, researchers can analyze the efficiency and specificity of peptide-MHC interactions, providing critical insights into the determinants of T cell activation and immune synapse formation. Such studies inform the broader understanding of how peptide epitopes are processed and displayed in cellular immunity.

T Cell Activation Assays: As a recognized epitope for cytotoxic T lymphocytes, this peptide is widely employed in functional assays designed to measure antigen-specific T cell responses. Its use enables the quantification of T cell activation, proliferation, and effector function in response to a defined target, facilitating the assessment of immune competence and the evaluation of T cell receptor specificity. These applications are instrumental in basic immunology research as well as in the development of immune monitoring strategies.

Epitope Mapping and Validation: The defined sequence of gp100 (154-162) allows for systematic epitope mapping in studies aimed at identifying immunodominant regions within the parent protein. By testing T cell responses to this and related overlapping peptides, investigators can delineate the minimal peptide motifs required for immune recognition. This approach supports the rational design of peptide-based probes and contributes to the refinement of antigen discovery pipelines.

Peptide-Based Assay Development: The synthetic nature and immunological relevance of this peptide make it an ideal standard in the development and optimization of peptide-based assays, such as enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and flow cytometry-based detection techniques. Its inclusion in assay validation protocols ensures the reproducibility and sensitivity of immune monitoring platforms, supporting comparative studies across different laboratories and experimental systems.

Vaccine and Immunotherapy Research Models: In preclinical settings, the gp100 (154-162) peptide is frequently incorporated into experimental vaccine formulations and immunotherapy protocols to evaluate the induction of antigen-specific cellular responses. Its use as a prototypical tumor-associated epitope enables the assessment of immunogenicity, the optimization of adjuvant systems, and the study of immune modulation strategies in vitro and in vivo. Such investigations contribute to the foundational knowledge required for advancing peptide-based immunotherapeutic approaches in research contexts.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L